AL-60371 Otic Suspension, 0.3%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-60371 Otic Suspension, 0.3%, covering 2014-06-18 to 2014-06-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa [Phase 3]